Navigation Links
Biotech Industry Showing Resilience Despite Challenging Conditions
Date:4/28/2010

the US market due largely to the adoption of new cost-cutting and efficiency measures.
  • Revenues of listed biotech companies fell by 9% to US$79.1 billion in 2009 from US$86.8 billion the prior year. The bulk of this decline was due to the exclusion of Genentech in 2009 as a result of its acquisition by large pharmaceutical company Roche. If Genentech is excluded from both years, industry revenues would have grown by 8%.
  • Capital raised increased sharply in 2009. Companies in the US, Europe and Canada raised US$23.2 billion in 2009, a 42% increase compared to 2008. A significant portion of this capital was raised by a handful of established public companies in follow-on offerings, as access to capital for many companies remained scarce.  
  • Strategic alliance activity remained robust -- in line with the record-breaking totals seen in the last couple of years. On the M&A side, with the exception of the Genentech transaction mentioned above, there were only three acquisitions larger than $US1 billion, due in part to several mega-mergers in big pharma, the buy side of most biotech deals.

  • "The European biotech community showed great fortitude in meeting the challenges of the economic downturn, with only a small reduction in the number of public companies," said Jurg Zurcher, Ernst & Young's Biotechnology Leader for Europe, Middle East, India and Africa. "With R&D funding essentially flat in 2009, European biotechs and their counterparts globally need to balance the need for cost cutting with ensuring they do not impair their ability to
    '/>"/>

    SOURCE Ernst & Young
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Immunovo BV- A New Biotechnology Company is Announced
    2. Maryland Biotechnology Center Supports $270,000 in MIPS Projects
    3. Reportlinker Adds Future of Red Biotechnology in China
    4. Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
    5. MedeFile Adds International Biotech Expert to Advisory Board
    6. Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results
    7. Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
    8. Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136
    9. UC San Diegos Biotech Demystified Program Offers Science Basics for Industry Leaders
    10. Global Nanobiotechnology Market to Reach $4.94 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
    11. Predicted Second Wave of Biotech Growth and Development Begins
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2014)... 17, 2014  United Therapeutics Corporation (NASDAQ: ... well as changes to Martine Rothblatt , Ph.D,s ... United Therapeutics announced the promotion of ... Officer and David Zaccardelli , Pharm.D. to Executive ... these promotions, Dr. Rothblatt,s title will change from Chairman ...
    (Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
    (Date:12/15/2014)... METTLER TOLEDO is pleased to announce that ... with PVM technology , is now available. The ... tool continuously captures high-resolution images under a wide ... prepares a report pairing the most relevant images ... This compelling blend of high resolution images and ...
    (Date:12/15/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology,  today celebrated continued ... its exVive3D TM Human Liver Tissue.  The ... commercial release on November 18, has been recognized ... awards for innovation. Most recently, on ...
    Breaking Biology Technology:United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3
    ... Germany, May 12 , - ... , The number of employees in ... 2006 and 2008. In this same period, the number of,companies ... These,figures were presented today by Dr. Klaus-Dieter Juszak, Chairman of ...
    ... treatment of Spinal Muscular Atrophy SOUTH PLAINFIELD, N.J. and ... and the Spinal Muscular Atrophy (SMA) Foundation today announced ... SMA Foundation will provide up to $8.5 million in ... of the collaboration to fund a series of research ...
    ... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ... has successfully completed patient enrolment in its multi-centre Phase ... REOLYSIN(R) in patients with various sarcomas that have metastasized ... been enrolled in the trial. , "We are extremely ...
    Cached Biology Technology:10,000 New Jobs, Investments Increased 210,000 New Jobs, Investments Increased 3PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration 2PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration 3Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study 2Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study 3
    (Date:12/19/2014)... Dec. 18, 2014 Research and Markets ... "Micro Market Monitor: North America Perimeter Security Systems ... http://photos.prnewswire.com/prnh/20130307/600769 The North American ... CAGR of 3.6% from 2014 to 2019. Although the ... Canada is expected to grow ...
    (Date:12/17/2014)... 15, 2014 Research and Markets ... the "Samsung Galaxy S5 - Home Button ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... sensing technology than the iPhone 5S, Samsung introduces ... its product. The Galaxy S5 home ...
    (Date:12/17/2014)... 16, 2014 Valencell, a leader in performance ... technology to industry leaders such as Intel, Jabra, Atlas, ... biometric wearable products. These products will be showcased at ... Las Vegas . "Our partners ... and robust – with the clinical data to back ...
    Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
    ... from the King Juan Carlos University (URJC) have carried ... looked at whether spiders were more tolerant of human ... suffer the consequences of changes to their landscape just ... number of spider species is negatively affected by the ...
    ... researchers from Tel-Aviv University show that predator-prey interactions between ... amphibians are much more complex than expected. The study ... Keys . , "Amphibians are typical insect predators and ... particular. The recently filmed successful attacks of the beetles ...
    ... from a late-night infomercial: It can twist and bend ... help you fend off disease! But in this ... including the U.S. Department of Energy,s Lawrence Berkeley National ... protein-making machine, the ribosome, at key stages of its ...
    Cached Biology News:Spiders suffer from human impact 2Small insects attacks and kill amphibians much bigger than themselves 2Atomic-scale structures of ribosome could help improve antibiotics 2Atomic-scale structures of ribosome could help improve antibiotics 3
    ... assay for monitoring acetylcholinesterase (AChE) activity. This ... than 5 min), non-radioactive and easy to ... the natural substrate, acetylcholine. A series of ... active AChE into a change in luminescence. ...
    ... The Pulsed Dynamic Focusing MALDI (PDF-MALDI) ... for samples that do not need online ... Ion Trap LC/MS and Agilents powerful Spectrum ... for fast analysis of 2D gel-spot digests. ...
    Rabbit polyclonal to Vitronectin ( Abpromise for all tested applications). Antigen: Full length Vitronectin protein (Mouse). Entrez Gene ID: 7448 Swiss Protein ID: P04004...
    ... Genie is an all-in-one rotator/rocker with ... five different mixing motions: rotating, ... well as a combination of all ... portion of the Vibraotme Roto-Shake Genie ...
    Biology Products: